MY148955A - Carbamoly-cyclohexanes for treating acute mania - Google Patents

Carbamoly-cyclohexanes for treating acute mania

Info

Publication number
MY148955A
MY148955A MYPI20094808A MYPI20094808A MY148955A MY 148955 A MY148955 A MY 148955A MY PI20094808 A MYPI20094808 A MY PI20094808A MY PI20094808 A MYPI20094808 A MY PI20094808A MY 148955 A MY148955 A MY 148955A
Authority
MY
Malaysia
Prior art keywords
acute mania
carbamoly
cyclohexanes
treating acute
dimethylcarbamoyl
Prior art date
Application number
MYPI20094808A
Other languages
English (en)
Inventor
Laszlovszky Istvan
Nemeth Gyorgy
Andor Gyorgy
Original Assignee
Richter Gedeon Nyrt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Nyrt filed Critical Richter Gedeon Nyrt
Publication of MY148955A publication Critical patent/MY148955A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965Non-condensed pyrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
MYPI20094808A 2007-05-24 2008-05-19 Carbamoly-cyclohexanes for treating acute mania MY148955A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU0700370A HUP0700370A2 (en) 2007-05-24 2007-05-24 Use of (thio)-carbamoyl-cyclohexane derivatives in the manufacture of a medicament for the treatment of acute mania

Publications (1)

Publication Number Publication Date
MY148955A true MY148955A (en) 2013-06-14

Family

ID=89987541

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20094808A MY148955A (en) 2007-05-24 2008-05-19 Carbamoly-cyclohexanes for treating acute mania

Country Status (26)

Country Link
US (1) US20100197704A1 (OSRAM)
EP (1) EP2164572B2 (OSRAM)
JP (1) JP2010527985A (OSRAM)
KR (1) KR20150076266A (OSRAM)
CN (2) CN105193807A (OSRAM)
AU (1) AU2008252621B2 (OSRAM)
CA (1) CA2687528C (OSRAM)
CY (1) CY1113566T1 (OSRAM)
DK (1) DK2164572T4 (OSRAM)
EA (1) EA021936B1 (OSRAM)
ES (1) ES2397962T5 (OSRAM)
GE (1) GEP20135731B (OSRAM)
HR (1) HRP20130092T4 (OSRAM)
HU (1) HUP0700370A2 (OSRAM)
IL (1) IL202048A (OSRAM)
MX (1) MX2009012752A (OSRAM)
MY (1) MY148955A (OSRAM)
NZ (1) NZ582284A (OSRAM)
PL (1) PL2164572T5 (OSRAM)
PT (1) PT2164572E (OSRAM)
RS (1) RS52613B2 (OSRAM)
SI (1) SI2164572T2 (OSRAM)
TW (1) TWI428130B (OSRAM)
UA (1) UA101323C2 (OSRAM)
WO (1) WO2008142463A2 (OSRAM)
ZA (1) ZA200908283B (OSRAM)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0700353A2 (en) * 2007-05-18 2008-12-29 Richter Gedeon Nyrt Metabolites of (thio)carbamoyl-cyclohexane derivatives
US7875610B2 (en) * 2007-12-03 2011-01-25 Richter Gedeon Nyrt. Pyrimidinyl-piperazines useful as D3/D2 receptor ligands
EP2251011B1 (en) * 2008-02-21 2012-04-04 Richter Gedeon Nyrt. Solid preparation for oral administration
SI2317852T1 (sl) 2008-07-16 2015-04-30 Richter Gedeon Nyrt. Farmacevtske formulacije, ki vsebujejo ligande dopaminskega receptorja
HU230067B1 (hu) 2008-12-17 2015-06-29 Richter Gedeon Nyrt Új piperazin só és eljárás előállítására
HUP0800766A2 (en) 2008-12-18 2010-11-29 Richter Gedeon Vegyeszet Process for the preparation of piperazine derivatives
HUP0800765A2 (en) 2008-12-18 2010-11-29 Richter Gedeon Nyrt A new process for the preparation of piperazine derivatives and their hydrochloric salts
US9610274B2 (en) * 2010-06-30 2017-04-04 Sk Biopharmaceuticals Co., Ltd. Methods for treating bipolar disorder
US8912197B2 (en) 2012-08-20 2014-12-16 Forest Laboratories Holdings Ltd. Crystalline form of carbamoyl-cyclohexane derivatives
US11274087B2 (en) 2016-07-08 2022-03-15 Richter Gedeon Nyrt. Industrial process for the preparation of cariprazine
US11547707B2 (en) 2019-04-10 2023-01-10 Richter Gedeon Nyrt. Carbamoyl cyclohexane derivatives for treating autism spectrum disorder

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS50680B (sr) * 2001-02-27 2010-06-30 Ortho-Mcneil Pharmaceutical Inc. Karbamatna jedinjenja za upotrebu u sprečavanju i lečenju bipolarnih poremećaja
HU227534B1 (en) * 2003-08-04 2011-08-29 Richter Gedeon Nyrt (thio)carbamoyl-cyclohexane derivatives, process for producing them and pharmaceutical compositions containing them
CA2756796C (en) * 2007-05-11 2018-05-22 Forest Laboratories Holdings Limited Novel solvate and crystalline forms of carbamoyl-cyclohexane derivatives

Also Published As

Publication number Publication date
DK2164572T3 (da) 2013-02-11
GEP20135731B (en) 2013-01-25
UA101323C2 (en) 2013-03-25
AU2008252621B2 (en) 2013-09-19
EA200971087A1 (ru) 2010-04-30
ZA200908283B (en) 2010-08-25
MX2009012752A (es) 2010-03-15
AU2008252621A1 (en) 2008-11-27
ES2397962T3 (es) 2013-03-12
CA2687528C (en) 2016-07-05
EP2164572B2 (en) 2015-09-16
HRP20130092T1 (en) 2013-02-28
NZ582284A (en) 2012-07-27
PL2164572T5 (pl) 2016-02-29
IL202048A (en) 2014-11-30
RS52613B (en) 2013-04-30
IL202048A0 (en) 2010-06-16
HK1136984A1 (en) 2010-07-16
WO2008142463A3 (en) 2009-03-05
WO2008142463A2 (en) 2008-11-27
CA2687528A1 (en) 2008-11-27
CY1113566T1 (el) 2016-06-22
SI2164572T2 (sl) 2016-01-29
PL2164572T3 (pl) 2013-04-30
US20100197704A1 (en) 2010-08-05
RS52613B2 (sr) 2018-05-31
DK2164572T4 (en) 2016-01-04
HU0700370D0 (en) 2007-07-30
CN101678212A (zh) 2010-03-24
CN105193807A (zh) 2015-12-30
TW201002326A (en) 2010-01-16
HUP0700370A2 (en) 2009-04-28
HRP20130092T4 (hr) 2016-01-01
KR20150076266A (ko) 2015-07-06
TWI428130B (zh) 2014-03-01
JP2010527985A (ja) 2010-08-19
SI2164572T1 (sl) 2013-02-28
EP2164572A2 (en) 2010-03-24
PT2164572E (pt) 2013-01-28
EP2164572B1 (en) 2012-11-14
ES2397962T5 (es) 2016-01-08
EA021936B1 (ru) 2015-10-30

Similar Documents

Publication Publication Date Title
MY148955A (en) Carbamoly-cyclohexanes for treating acute mania
PL2164492T3 (pl) Trans-4-{2-[4-(2,3-dichlorofenylo)-piperazyn 1-ylo]-etylo}-N,Ndimetylokarbamoilocykloheksylamina do leczenia schizofrenii
MY150784A (en) Metabolites of (thio) carbamoyl-cyclohexane derivatives
UA102517C2 (ru) Замещенные производные морфолина и тиоморфолина, фармацевтическая композиция на их основе и их применение для производства лекарственного средства для лечения расстройства или заболевания центральной нервной системы
WO2010088000A3 (en) Antifibrotic compounds and uses thereof
PH12015502628B1 (en) Pyrazolopyrrolidine derivatives and their use in the treatment of disease
NZ612000A (en) Bicyclo[3.2.1]octyl amide derivatives and uses of same
MX2015016344A (es) Derivados de imidazo-pirrolidinona y su uso en el tratamiento de enfermedades.
BRPI0412999A (pt) 2-aminotetralina substituìda para tratamento de depressão
BRPI0316908B8 (pt) preparo de suspensões aquosas estéreis incluindo ingredientes ativos cristalinos micronizados para inalação
PH12019502566A1 (en) Pharmacologically active alicyclic-substituted pyrazolo[1,5-a] pyrimidine derivatives
TN2009000275A1 (en) Use of substituted pyranone acid derivatives for the treatment of metabolic syndrome
TW200510321A (en) Substituted 4-phenyltetrahydroisoquinolines, process for preparing them, their use as a medicament, and medicament comprising them
NZ594157A (en) Sulfonamide compounds for the treatment of respiratory disorders
TW200635575A (en) Use of substituted cyclopropane acid derivatives for producing medicaments for treating the metabolic syndrome
UA101341C2 (ru) Терапевтические применения соединений, которые имеют комбинированную активность в отношении sert, 5-нт3 и 5-нт1a
TH157552A (th) องค์ประกอบทางเภสัชกรรมและวิธีสำหรับรักษาอาการฟุ้งพล่านแบบเฉียบพลัน